Metraipolis › archive › dc_bb310deadf2e

FGFR inhibitor resistance in cervical cancer: a role for integrin α2 and mTOR signalling — Europe PMC PMID:42326010

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42326010
DOI: 10.3389/fcell.2026.1863679
License (as archived): solo-consultazione
Archived: 2026-10-31T19:17:31.444Z
SHA-256 of the archived text: 86564cf1243e6cc88f6cf1e7ec5ff078e566669599266902673fcf90d8814b4b
Stable URL of this page: https://metraipolis.com/documento/dc_bb310deadf2e

How to cite

FGFR inhibitor resistance in cervical cancer: a role for integrin α2 and mTOR signalling — Europe PMC PMID:42326010 — Europe PMC (en), https://europepmc.org/article/MED/42326010 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb310deadf2e (Metraipolis archive dc_bb310deadf2e, sha256 86564cf1243e6cc88f6cf1e7ec5ff078e566669599266902673fcf90d8814b4b)

BibTeX

@misc{dcbb310deadf2e,
  title = {FGFR inhibitor resistance in cervical cancer: a role for integrin α2 and mTOR signalling — Europe PMC PMID:42326010},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42326010},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb310deadf2e; sha256 86564cf1243e6cc88f6cf1e7ec5ff078e566669599266902673fcf90d8814b4b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42326010. Agents can read the archived copy with the MCP tool read_document.